Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrustpilot Regulatory News (TRST)

Share Price Information for Trustpilot (TRST)

Share Price is delayed by 15 minutes
Get Live Data
236.80    -7.20 (-2.95%)
Bid:
236.80
Ask:
237.60
Spread: 0.80 (0.338%)
Market Cap: £914.97m
TRST Live PriceLast checked at - London Stock Exchange

Intraday Trustpilot Share Chart

Exercise of Over-allotment Option

16 Apr 2021 17:39

RNS Number : 7979V
Trustpilot Group PLC
16 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

16 April 2021

 

 

Trustpilot Group plc

 

Exercise of Over-allotment Option

 

Further to its announcement on 23 March 2021 relating to its initial public offering (the "Offer"), Trustpilot Group plc ("Trustpilot") announces that Morgan Stanley & Co. International plc, acting as the stabilising manager, has today given notice to exercise the over-allotment option (the "Over-allotment Option") granted by DFJ Europe X, L.P., Esprit Capital III Founder L.P., Esprit Capital III L.P., Esprit Capital IV LP, Index Ventures Growth II (Jersey), L.P., Index Ventures Growth II Parallel Entrepreneur Fund (Jersey), L.P., Index Ventures VI (Jersey), L.P., Index Ventures VI Parallel Entrepreneur Fund (Jersey), L.P., Yucca (Jersey) SLP, Northzone VI L.P., SEED Capital Denmark II K/S and SEED Capital Denmark II 2019 K/S in respect of 3,291,602 ordinary shares in Trustpilot at the offer price of 265 pence per share.

 

Giving effect to the exercise of the Over-allotment Option, the final size of the Offer is approximately £482 million (approximately 181.9 million ordinary shares), representing approximately 44.4 per cent. of the ordinary shares in Trustpilot.

 

Enquiries:

Tulchan (Public Relations adviser to Trustpilot)

James Macey White, Sunni Chauhan and Matt Low

+44 (0)20 7353 4200

trustpilot@tulchangroup.com

 

Morgan Stanley

Tom Perry / Angus Millar / Bobak Shoraka / Anisha Singhal

+44 (0)207 425 8000

 

 

Important Legal Information

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete, nor does this announcement constitute or form part of any invitation or inducement to engage in investment activity. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness. The contents of this announcement are not to be construed as legal, financial or tax advice.

This announcement and the information contained herein is not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for, or otherwise invest in, securities to any person in any jurisdiction, including the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to herein may not be offered, sold or resold in the United States unless registered under the United States Securities Act of 1933, as amended (the "Securities Act") or in a transaction exempt from, or not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been, and will not be, registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. Subject to certain exceptions, the Shares referred to herein may not be offered, sold or resold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. There was no, and will be no, public offer of the securities referred to herein in the United States, Australia, Canada, Japan, or elsewhere.

Certain data in this announcement, including financial, statistical, and operating information has been rounded. As a result of the rounding, the totals of data presented in this announcement may vary slightly from the actual arithmetic totals of such data. Percentages may have been rounded and accordingly may not add up to 100%.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFWFMMEFSEDL
Date   Source Headline
22nd Jun 20267:26 amRNSTransaction in Own Shares
16th Jun 20263:24 pmRNSDirector Declaration
15th Jun 20267:24 amRNSTransaction in Own Shares
8th Jun 20267:27 amRNSTransaction in Own Shares
1st Jun 20267:26 amRNSTransaction in Own Shares
29th May 20261:53 pmRNSTotal Voting Rights
26th May 20267:34 amRNSTransaction in Own Shares
19th May 20264:41 pmRNSResult of AGM
19th May 20261:00 pmRNSCEO’s Comments at the 2026 Annual General Meeting
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20269:34 amRNSHolding(s) in Company
12th May 20266:17 pmRNSHolding(s) in Company
11th May 20267:59 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTrust Capital Markets Event
5th May 202611:17 amRNSTransaction in Own Shares
1st May 20265:01 pmRNSHolding(s) in Company
30th Apr 20262:03 pmRNSTotal Voting Rights
27th Apr 202611:47 amRNSTrustpilot to host Trust education event
27th Apr 20267:28 amRNSTransaction in Own Shares
24th Apr 202610:16 amRNSHolding(s) in Company
23rd Apr 20262:31 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:07 amRNSDirector Declaration
21st Apr 20267:00 amRNSAppointment of Non-Executive Director
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:38 pmRNS2025 Annual Report and Notice of 2026 AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:23 pmRNSDirector/PDMR Shareholding
7th Apr 20268:31 amRNSDirector/PDMR Shareholding
7th Apr 20268:14 amRNSTransaction in Own Shares
31st Mar 20264:56 pmRNSTotal Voting Rights
30th Mar 20268:27 amRNSTransaction in Own Shares
27th Mar 20264:13 pmRNSBlock Admission Application
26th Mar 20264:10 pmRNSDirector/PDMR Shareholding
25th Mar 20267:05 amRNSCompletion of share buyback programme
24th Mar 20263:54 pmRNSDirector/PDMR Shareholding
24th Mar 20263:45 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAppointment of Marcus Roy as CFO
24th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSResults of secondary placing in Trustpilot
23rd Mar 20262:03 pmRNSTrustpilot to appeal AGCM finding
20th Mar 202611:20 amRNSHolding(s) in Company
19th Mar 20263:19 pmRNSDirector/PDMR Shareholding
19th Mar 20262:59 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSShare Buyback Programme
17th Mar 20267:00 amRNSShare Buyback Programme
17th Mar 20267:00 amRNSProfitability ahead of expectations
17th Mar 20267:00 amRNSProfitability ahead of expectations
16th Mar 20263:09 pmRNSHolding(s) in Company
16th Mar 20263:09 pmRNSHolding(s) in Company
16th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.